hnRNPM’s protective role in protein synthesis precision uncovered

FHS
May 30, 2024
8:04 am

Researchers at Baylor College of Medicine and collaborating institutions have discovered that a protein called hnRNPM helps protect the integrity of the process cells use to make proteins.

Self-amplifying RNA and vaccine innovation: getting from concept to clinic – Pharmaceutical Technology

Self-amplifying RNA (saRNA) could offer significant advantages – but the technology’s relative novelty means biomanufacturers must tread carefully. Credit: metamorworks / Shutterstock.com. A GlobalData conducted

May 28, 2024

Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications | Psychedelic Invest

Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals

September 14, 2023

4 medtech companies to watch this week in earnings

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Investor concerns about weaker order growth in

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.